-
Forward Look
Truth in AdvertisingSeveral countries explore legality of requiring cigarettes to carry graphic pictures and health warnings.
by Sue Rochman
-
Forward Look
Coming Up ShortA limited supply of cancer medications is affecting care.
by Steve McIver
-
Survivor Profile
Betting on ScienceDiagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.
by Betty Russell
-
Get Involved
Sending Get Well WishesJoan A. Smith organizes volunteers' efforts to send cards to cancer patients.
by Maria Wolf
-
More Than a Signature
The informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
-
Editor's Letter
Cancer Research: Worth Paying ForKevin McLaughlin discusses how one survivor's faith in science underscores the importance of continued funding for cancer research.
by Kevin McLaughlin
-
Editor's Letter
Making PlansA cancer diagnosis can quickly change your “other plans.”
by Kevin McLaughlin
-
Forward Look
When the Cancer Doctor Gets CancerQ & A with breast surgeon Susan Love on her new role: cancer survivor.
by Betty Russell
-
Forward Look
Paying a Steep PriceNew laws are pushing health insurers to make oral cancer drugs affordable.
by Betty Russell
-
Forward Look
This Way to the Quit LineDoctors and researchers are encouraged to talk to patients about tobacco use.
by Sue Rochman
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore